This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various biologically active molecules. Its structure, which includes a piperazine ring and fluorophenyl groups, makes it valuable in the development of central nervous system (CNS) drugs, particularly those targeting neurological disorders such as depression, anxiety, and schizophrenia. The presence of the fluorophenyl groups enhances its ability to interact with specific receptors in the brain, while the piperazine ring contributes to its pharmacokinetic properties, improving solubility and bioavailability. Additionally, it may be explored in the research and development of antihistamines or antipsychotic medications due to its potential to modulate neurotransmitter activity. Its application extends to preclinical studies where it is used to investigate structure-activity relationships and optimize drug candidates for therapeutic efficacy.